Stakeholders request elaboration, consistency in FDA’s non-interventional RWE studies guidance
Regulatory NewsEmily Hayes
Biologics/ biosimilars/ vaccinesGuidancePharmaceuticalsProduct LifecycleRWE/RWDUnited StatesRegulatory NewsEmily HayesBiologics/ biosimilars/ vaccinesGuidancePharmaceuticalsProduct LifecycleRWE/RWDUnited States